Description
RosiglitazoneisathiazolidinedioneinsulinsensitizerthatactivatesPPARγ,decreasingbloodglucoseandinsulinlevels.Rosiglitazoneexhibitsanti-diabetic,anti-inflammatory,antioxidative,anticancer,anti-angiogenic,antihypertensive,andanti-fibroticactivities.Invivo,rosiglitazonedecreasesLPS-stimulatedproductionofTNF-α,IL-1β,andIL-6aswellasactivityofmyeloperoxidase;italsoinhibitsactivationofNF-κB,preventingmastitis.Inmultiplemyelomacells,rosiglitazonesuppressesexpressionofHIF-1αandIGF-1,decreasesactivationofAky,andERK,andinhibitscellviABIlityandproliferation.Thiscompoundalsoinhibitsendothelin-1-inducedvasoconstrictioninaNO-dependentmannerinanimalmodelsofpulmonaryarterialhypertension.Additionally,rosiglitazonepreventsactivationofAP-1,productionofcollagen,anddifferentiationinfibroblasts.